About the study
Mana Medical have now developed a pre-release app which helps you balance rest and activity each day to reduce the risk of flare-ups of pain and fatigue. This is achieved by a novel ‘body battery’ score being generated in the app. See the prototype for an insight into the app.
You will have an iOS (Apple iPhone) phone, be required to be a resident in the UK, living with Rheumatoid Arthritis (RA) and have an existing wearable device which tracks things like step count and heart rate. At this stage of the development of the app, you would be required to have one of the following:
- Apple Watch: Sept 2020 - present (version 6 or above)
- Samsung Galaxy: Oct 2023 - present (version 6 or above)
- Garmin - all models apart from the smartbands
The wearable device and the app will combine daily symptom inputs to generate a daily recommendation around physical activity. You will also receive two monthly insight reports at the end of each 4 week period, combining information about your medications, physical activity / wearable data, daily symptom inputs and any reported side effects or other journal information provided. All data collected will be anonymised to ensure privacy and used solely for research purposes. For further information about the study, please review the participant information sheet here.
If you own an Apple iPhone with a wearable device not the above, an Android or Windows phone and are interested in taking part in future trials, please complete this Register Future Interest form.
Your Involvement
We are looking for participants willing to help test this over 8 weeks, so that Mana Medical can refine data science and user experience to deliver real daily use around disease management. During this research project there will be onboarding instructions on how the app plugs into your existing wearable to give access to things like your step count and heart rate. There will be a need to answer approx. 30 seconds of questions each morning in the app for the entirety of the 8 weeks on your daily symptoms.